HUP0201975A2 - Polypeptide dendrimers as unimolecular carriers of diagnostic imaging contrast agents, bioactive substances and drugs - Google Patents

Polypeptide dendrimers as unimolecular carriers of diagnostic imaging contrast agents, bioactive substances and drugs

Info

Publication number
HUP0201975A2
HUP0201975A2 HU0201975A HUP0201975A HUP0201975A2 HU P0201975 A2 HUP0201975 A2 HU P0201975A2 HU 0201975 A HU0201975 A HU 0201975A HU P0201975 A HUP0201975 A HU P0201975A HU P0201975 A2 HUP0201975 A2 HU P0201975A2
Authority
HU
Hungary
Prior art keywords
drugs
contrast agents
diagnostic imaging
bioactive substances
imaging contrast
Prior art date
Application number
HU0201975A
Other languages
Hungarian (hu)
Inventor
Antonio Verdini
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of HUP0201975A2 publication Critical patent/HUP0201975A2/en
Publication of HUP0201975A3 publication Critical patent/HUP0201975A3/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/641Branched, dendritic or hypercomb peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HU0201975A 1999-07-23 2000-07-21 Polypeptide dendrimers as unimolecular carriers of diagnostic imaging contrast agents, bioactive substances and drugs HUP0201975A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT1999FO000015A ITFO990015A1 (en) 1999-07-23 1999-07-23 "POLYPEPTIDE DENDRIMERS AS UNIMOLECULAR CARRIERS OF DRUGS AND BIOLOGICALLY ACTIVE SUBSTANCES".

Publications (2)

Publication Number Publication Date
HUP0201975A2 true HUP0201975A2 (en) 2002-10-28
HUP0201975A3 HUP0201975A3 (en) 2002-11-28

Family

ID=11353680

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0201975A HUP0201975A3 (en) 1999-07-23 2000-07-21 Polypeptide dendrimers as unimolecular carriers of diagnostic imaging contrast agents, bioactive substances and drugs

Country Status (12)

Country Link
EP (1) EP1200461A2 (en)
JP (1) JP2003506326A (en)
CN (1) CN1364171A (en)
AU (1) AU772167B2 (en)
CA (1) CA2380178A1 (en)
HU (1) HUP0201975A3 (en)
IT (1) ITFO990015A1 (en)
NO (1) NO20020333D0 (en)
NZ (1) NZ517231A (en)
PL (1) PL353273A1 (en)
WO (1) WO2001007469A2 (en)
ZA (1) ZA200201089B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY139353A (en) 2001-03-05 2009-09-30 Shell Int Research Process to prepare a lubricating base oil and a gas oil
MY137259A (en) 2001-03-05 2009-01-30 Shell Int Research Process to prepare a lubricating base oil and a gas oil.
AR032941A1 (en) 2001-03-05 2003-12-03 Shell Int Research A PROCEDURE TO PREPARE A LUBRICATING BASE OIL AND BASE OIL OBTAINED, WITH ITS VARIOUS USES
DE60128011T2 (en) * 2001-10-29 2007-12-27 Dendritic Nanotechnologies, Inc., Mt. Pleasant DISPENSING SYSTEM FOR ANTINEOPLASTIC MEDICAMENTS BASED ON DENDRITIC POLYMERS
JP4629435B2 (en) 2002-07-18 2011-02-09 シエル・インターナシヨネイル・リサーチ・マーチヤツピイ・ベー・ウイ Process for producing microcrystalline wax and middle distillate fuel
EP1525890A1 (en) * 2003-10-02 2005-04-27 Complex Biosystems GmbH Protein-Proteophore complexes
WO2007061896A1 (en) 2005-11-17 2007-05-31 Zogenix, Inc. Delivery of viscous formulations by needle-free injection
HUP0700782A3 (en) * 2007-12-05 2009-11-30 Biostatin Gyogyszerkutato Fejl Novel peptides and amino acid derivatives, pharmaceutical compositions containing the same and use of the compounds
EP2756756B1 (en) 2008-04-28 2016-01-06 Zogenix, Inc. Novel formulations for treatment of migraine
WO2010015022A1 (en) * 2008-08-05 2010-02-11 The University Of Queensland Antigen-presenting scaffolds

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995000540A1 (en) * 1993-06-18 1995-01-05 Robert Webber Synthetic carrier and immunogen
WO1998032469A2 (en) * 1997-01-29 1998-07-30 Nycomed Imaging As Polymers

Also Published As

Publication number Publication date
PL353273A1 (en) 2003-11-03
WO2001007469A3 (en) 2001-05-10
ZA200201089B (en) 2003-07-30
JP2003506326A (en) 2003-02-18
ITFO990015A1 (en) 2001-01-23
CA2380178A1 (en) 2001-02-01
NZ517231A (en) 2003-05-30
AU6276600A (en) 2001-02-13
CN1364171A (en) 2002-08-14
EP1200461A2 (en) 2002-05-02
NO20020333L (en) 2002-01-22
HUP0201975A3 (en) 2002-11-28
WO2001007469A2 (en) 2001-02-01
NO20020333D0 (en) 2002-01-22
AU772167B2 (en) 2004-04-08

Similar Documents

Publication Publication Date Title
HUP0203325A3 (en) Bicyclic amino acids, pharmaceutical compositions containing them and their use
CZ20012028A3 (en) Novel N-substituted 2-cyanopyrrolidines, pharmaceutical preparation in which they are comprised and their use as medicament
HUP0004400A3 (en) Dipeptide nitriles, process for their preparation, pharmaceutical compositions comprising thereof and their use
ZA200202996B (en) Hair treatment compositions comprising particulate substances.
HUP0204413A3 (en) Quinazoline compounds, their preparation, their use and pharmaceutical compositions containing them
HUP0100270A3 (en) Peptids for inhibiting betha-amyloid peptide release and/or its synthesis, pharmaceutical compositions comprising thereof and their use
HUP0200831A2 (en) Novel pharmaceutical composition containing amoxycillin and its use
EE200200046A (en) 8-Phenyl-6,9-dihydro- [1,2,4] triazolo [3,4-i] purin-5-one derivative, its preparation and therapeutic use, and pharmaceutical composition containing it
HUP0103265A3 (en) Cyclic prosaposin-derived peptides, pharmaceutical compositions comprising thereof and their use
HUP0204081A3 (en) 4-pyrimidinyl-n-acyl-l-phenylalanines, pharmaceutical compositions containing them and their use
HUP0203194A3 (en) Phenylpiperazines, pharmaceutical compositions containing them and their use
HUP0201975A2 (en) Polypeptide dendrimers as unimolecular carriers of diagnostic imaging contrast agents, bioactive substances and drugs
NZ513650A (en) Pharmaceutical composition for the treatment of urinary incontinence, motion sickness and vertigo
ZA991974B (en) Bicyclic aromatic compounds and their use in human or veterinary medicine, as well as in cosmetology.
IL156262A0 (en) Anti-cd28 antibodies having no mitogenic activity and pharmaceutical compositions containing the same
EP1210416A4 (en) Novel genes encoding proteins having diagnostic, preventive, therapeutic, and other uses
HUP0201910A3 (en) Novel aminobenzophenones, pharmaceutical compositions containing them and their use
HK1029928A1 (en) Pharmaceutical compositions of peptides having lowsolubility in physiological medium.
IL152202A0 (en) Human kcnq5 polypeptide and pharmaceutical compositions containing the same
HUP0201696A2 (en) Cyclic peptides, pharmaceutical compositions comprising thereof and their use
ZA200109989B (en) Pharmaceutical composition containing sibutramine and orlistat.
DE69831223D1 (en) FREEZE-DRIED COMPOSITION OF THE HUMAN, MORPHOGOUS BONE PROTEIN MP52
IL121329A (en) Pharmaceutical composition for the treatment of cancer comprising somatostatin2 and other peptides
HU9802590D0 (en) Sulfonamid-substituted and condensed compounds containing 5-membred ring, their use as medicament and pharmaceutical compositions containing them
HUP0203181A3 (en) Peptides for treatment of erectile dysfunction, pharmaceutical compositions and their use